Consult a healthcare professional before use if you are pregnant, breastfeeding, or have underlying health conditions
Sezikli M, Cetinkaya ZA, Guzelbulut F, Yesil A, Cosgun S, Kurdas OO
Pompella A, Visvikis A, Paolicchi A, De Tata V, Casini AF
While the committee's recommendations are not final FDA decisions, they are an important step in the FDA's review process
This locally-produced pancreatic DA signals via both - and -cell adrenergic and dopaminergic receptors with different affinities to regulate glucagon and insulin release
The successful implementation of GLP-1-based therapies could lead to decreased hospitalization rates, lower healthcare costs, and improved quality of life for patients